Ligand(LGND) - 2022 Q4 - Earnings Call Transcript

royalty generating asset portfolio and positions us for strong continued growth. Tavo, our CFO will provide more 2022 financial results, as well as our increased '23 financial guidance. Rylaze marketed by Jazz is a recombinant Erwinia asparaginase used for a component of a multi-agent chemotherapeutic regimen for the treatment of children and adults with ALL or LBL. This product continues to do well in the market that was historically constrained by supply issues for the previous standard of care product. S ...